The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European and South American countries; findings and implications for the future
| dc.contributor.author | Gambogi Rosana., | |
| dc.contributor.author | Alutuli Luke., | |
| dc.contributor.author | Zikria Saleem...(et .al) | |
| dc.date.accessioned | 2025-06-26T09:20:18Z | |
| dc.date.available | 2025-06-26T09:20:18Z | |
| dc.date.issued | 2021-06 | |
| dc.identifier.uri | DOI: •10.3389/fpubh.2021.671961 | |
| dc.identifier.uri | http://41.89.96.81:4000/handle/123456789/1702 | |
| dc.language.iso | en | |
| dc.publisher | Frontiers in Public Health | |
| dc.title | The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European and South American countries; findings and implications for the future | |
| dc.type | Article |
Files
Original bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- The current situation regarding long-acting insulin analogues including biosimilars among African, Asian, European and South American countries; findings and implications for the future.pdf
- Size:
- 10.45 KB
- Format:
- Adobe Portable Document Format
License bundle
1 - 1 of 1
No Thumbnail Available
- Name:
- license.txt
- Size:
- 1.71 KB
- Format:
- Item-specific license agreed to upon submission
- Description: